Lockdown Measures Negatively Impacted Cancer Care

Kumari, Sarita; Mahla, Ranjeet Singh; Mangone, Lucìa; Rossi, Paolo; Grilli, Roberto; Pinto, Carmine; Ferrara, Gerardo; Vincentiis, Ludovica De; Crivelli, Filippo; Feyles, Elda; Orvieto, Enrico; Venturino, Ezio; Saragoni, Luca; Barbareschi, M.

doi:10.1093/ajcp/aqaa243

Cited by 11 publications

(15 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is interesting to note that, with reference to the data from two previous studies, there was a sharp decline in all malignant tumors during the first wave in Italy (À44.9% Ferrara and À37% Kumara-Mangone compared to 2019), but the decrease was smaller for the diagnosis of lung cancer (À27.5% Ferrara and À22% Kumara-Mangone). 4,12 There was also a progressive decline in lung cancer diagnoses in the United StatesA during the first 4 months of 2020 (4%, À8%, À24%, and À47%, respectively) 13 ; the authors stated that the decline was expected for cancers such as breast, colorectal, and prostate cancer but less so for lung cancer, as the initial symptoms are similar to those of COVID-19. The Netherlands also saw a decrease in new cancer diagnoses, which was also appreciable for lung cancer.…”

Section: Discussionmentioning

confidence: 99%

“…Bladder cancer, colorectal cancer, and prostate cancer diagnoses decreased by 66%, 62%, and 75%, respectively. 4 The most probable hypothesis is that this decrease in the number of diagnoses reflects a delay in access to testing and assessment related to the COVID-19 pandemic and to infection-control measures. 4 How much this delay caused a shift to more advanced disease at diagnosis, and therefore with a potentially worse prognosis, probably depended on the cancer site and on how the regional health systems reacted to the pandemic; this is an important public health question to be answered over the next few years.…”

Section: Introductionmentioning

confidence: 99%

“…4 The most probable hypothesis is that this decrease in the number of diagnoses reflects a delay in access to testing and assessment related to the COVID-19 pandemic and to infection-control measures. 4 How much this delay caused a shift to more advanced disease at diagnosis, and therefore with a potentially worse prognosis, probably depended on the cancer site and on how the regional health systems reacted to the pandemic; this is an important public health question to be answered over the next few years. 5 The aim of this work was to evaluate the impact of the COVID-19 pandemic on the number of new MM diagnoses in relation to the phase of the pandemic and geographical area.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

The impact of COVID‐19 on new mesothelioma diagnoses in Italy

et al. 2022

Self Cite

View full text Add to dashboard Cite

Background: The aim of this work was to evaluate the impact of the restrictions put in place to control the COVID-19 pandemic on new diagnoses of malignant mesothelioma (MM) in Italy. Methods: Twelve of the 21 Italian malignant mesothelioma CORs (regional operating centres) participated. The study included all cases of MM with microscopic confirmation; cases without microscopic confirmation and death certificate only (DCO) were excluded. For each case, information on sex, date of birth, tumor site, morphology, and date of diagnosis was retrieved. We compared the number of incident cases in 2020 with 2019, looking at the overall picture and for four periods: pre-pandemic (January-February), first wave (March-May), low incidence (June-September), and second wave (October-December). Results: A total of 604 cases were registered: 307 in 2019 and 297 in 2020. In the 2020 pre-pandemic period, the incidence was higher than in the same months in 2019

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The impact of COVID‐19 on new mesothelioma diagnoses in Italy

et al. 2022

Self Cite

View full text Add to dashboard Cite

show abstract

“…A decline in cancer diagnoses was observed in most countries where it has been investigated and for almost all tumour sites [ 10 , 11 , 14 , 24 , 25 , 26 ], in particular for those subject to screening [ 12 , 27 , 28 , 29 , 30 , 31 ]. The recovery of post-lockdown diagnosis almost never compensates for the previously observed decline [ 15 , 29 , 30 , 32 ].…”

Section: Discussionmentioning

confidence: 91%

“…All of this healthcare reorganization has had a strong impact on new cancer diagnoses of tumours in general [ 10 , 11 ] and of cancers screened in particular [ 12 , 13 ]: in Italy, Ferrara and colleagues showed a 38.2% decrease in new breast cancer diagnoses [ 14 ], which was subsequently confirmed [ 15 ].…”

Section: Introductionmentioning

confidence: 99%

Prompt Resumption of Screening Programme Reduced the Impact of COVID-19 on New Breast Cancer Diagnoses in Northern Italy

Mangone

Mancuso

Braghiroli

et al. 2022

Cancers

Self Cite

View full text Add to dashboard Cite

The aim of this study is to evaluate the real impact of COVID-19 during the entire 2020 period, compared with 2019. The data comes from a Cancer Registry in Northern Italy and we compared clinical and treatment characteristics of breast cancer by age, stage, treatment, and status screening. In 2020 there was no decrease in invasive tumours nor in in situ (513 vs. 493 and 76 vs. 73, respectively), while there was a significant decrease in surgery and increase in neoadjuvant chemotherapy (p = 0.016). In the screening range (aged 45–74), no change in stage and grading was observed. In the four periods examined there was an increase in new diagnoses during pre-lockdown, a decrease in tumours especially at age 75+ [IRR 0.45; 95%CI 0.25–0.79] during lockdown, a recovery of new diagnoses in women 45+ in the low incidence period while in the last period there was a significant increase only for ages 45–74 [IRR 1.48; 95%CI 1.11–1.98]. Screening activities were suspended from March to May, but over the summer and autumn the backlog was addressed. This suggests that a prompt resumption of programmed screening may have limited the impact of the pandemic on the delay of breast cancer diagnoses.

show abstract

The impact of the Covid-19 pandemic on Italian population-based cancer screening activities and test coverage: results from national cross-sectional repeated surveys

Rossi

Carrozzi

Falini³

et al. 2022

Preprint

View full text Add to dashboard Cite

Background In Italy, population-based screening programs for breast, cervical and colorectal cancers are mandatory, and Regions are in charge of their delivery. From March to May 2020, a severe lockdown was imposed due to the Covid-19 pandemic by the Italian Ministry of Health, with the suspension of screening programs. This paper describes the impact of the pandemic on Italian screening activities and test coverage in 2020. Methods The regional number of subjects invited and of screening tests performed in 2020 were compared with those in 2019. Invitation and examination coverage were also calculated. PASSI surveillance system, through telephone interviews, investigated the population screening test coverage, before and during the pandemic, accordingly to educational attainment, perceived economic difficulties and citizenship. Results A reduction of subjects invited and tests performed, with differences among periods and geographic macro areas, was observed in 2020 vs. 2019. The reduction in examination coverage was larger than that in invitation coverage for all screening campaigns. From the second half of 2020, the trend for test coverage showed a decrease in all the macro areas for all the screening campaigns. Compared with the pre-pandemic period, there was a greater difference according to level of education in the odds of having had a test last year vs. never having been screened or not being up to date with screening tests. In addition, foreigners had less access to screening than Italians did. Conclusions The lockdown and the ongoing Covid-19 emergency caused an important delay in screening activities. This increased the pre-existing individual and geographical inequalities in access. The opportunistic screening did not mitigate the pandemic impact. FundingThis study was partially supported by Italian Ministry of Health – Ricerca Corrente Annual Program 2023.

show abstract

Lockdown Measures Negatively Impacted Cancer Care

Cited by 11 publications

References 5 publications

The impact of COVID‐19 on new mesothelioma diagnoses in Italy

The impact of COVID‐19 on new mesothelioma diagnoses in Italy

Prompt Resumption of Screening Programme Reduced the Impact of COVID-19 on New Breast Cancer Diagnoses in Northern Italy

The impact of the Covid-19 pandemic on Italian population-based cancer screening activities and test coverage: results from national cross-sectional repeated surveys

Contact Info

Product

Resources

About